New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives

M Terreni, M Taccani, M Pregnolato - Molecules, 2021 - mdpi.com
The present work aims to examine the worrying problem of antibiotic resistance and the
emergence of multidrug-resistant bacterial strains, which have now become really common …

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America

DL Stevens, AL Bisno, HF Chambers… - Clinical infectious …, 2014 - academic.oup.com
We have examined the effect of profound hypothermia on gut mucosal perfusion in 20
infants, aged 1.4-45 weeks, requiring cardiopulmonary bypass (CPB). After induction of …

Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections

MS Linz, A Mattappallil, D Finkel, D Parker - Antibiotics, 2023 - mdpi.com
The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and …

C Liu, A Bayer, SE Cosgrove, RS Daum… - Clinical infectious …, 2011 - academic.oup.com
To clarify whether apoptosis is involved in the injury processes induced by autoantibody
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …

Current epidemiology, etiology, and burden of acute skin infections in the United States

KS Kaye, LA Petty, AF Shorr… - Clinical Infectious …, 2019 - academic.oup.com
The US burden of acute skin infections is substantial. While Staphylococcus aureus and
Streptococcus spp. are the most common causes, gram-negative bacteria and mixed …

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non …

GJ Moran, E Fang, GR Corey, AF Das… - The Lancet Infectious …, 2014 - thelancet.com
Background New antibiotics are needed to treat infections caused by drug-resistant bacteria.
Tedizolid is a novel oxazolidinone antibacterial drug designed to provide enhanced activity …

Global fluoroquinolone resistance epidemiology and implictions for clinical use

A Dalhoff - Interdisciplinary perspectives on infectious diseases, 2012 - Wiley Online Library
This paper on the fluoroquinolone resistance epidemiology stratifies the data according to
the different prescription patterns by either primary or tertiary caregivers and by indication …

Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment

AF Cardona, SE Wilson - Clinical Infectious Diseases, 2015 - academic.oup.com
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality
among hospitalized patients and a major therapeutic challenge for clinicians. Although …

Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008

DA Talan, A Krishnadasan, RJ Gorwitz… - Clinical Infectious …, 2011 - academic.oup.com
Background. In the past decade, new methicillin-resistant Staphylococcus aureus (MRSA)
strains have emerged as a predominant cause of community-associated skin and soft-tissue …